March 14, 2012

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

March 14, 2012

The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

March 14, 2012

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

March 14, 2012

Pharmaceutical wholesaler H.D. Smith has appointed Bill Williams as CFO, the company said Wednesday.

March 13, 2012

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 12, 2012

Mylan is getting new headquarters, the company said.

March 9, 2012

The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said.

March 9, 2012

A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

March 9, 2012

A company that makes pet drugs has launched what it calls the first generic prescription heartworm preventive medication for sale at retail pharmacies around the country.

March 9, 2012

The National Association of Chain Drug Stores on Friday applauded the Senate for passage of the Counterfeit Drug Penalty Enhancement Act (S. 1886), which NACDS said would protect the health and safety of consumers by increasing penalties on criminals that engage in the harmful practice of trafficking in counterfeit medications.

March 8, 2012

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.

March 8, 2012

The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

March 7, 2012

Prices for generic drugs may be dropping, but increases in branded and specialty drug prices have offset those decreases, according to a new study.

March 5, 2012

Indian drug maker Dr. Reddy's has launched a drug designed to treat bipolar disorder and schizophrenia, the company said.

March 5, 2012

Cardinal Health can continue distributing controlled medications from a distribution center in Florida, according to published reports.

March 2, 2012

The Centers for Disease Control and Prevention on Friday issued its latest update on the influenza season to date, or rather the lack thereof. For the week ended Feb. 25, visits for influenza-like illnesses have yet to crack the national baseline of 2.4% this season.

March 2, 2012

An organization representing independent retail pharmacies is criticizing a new ad by a pharmacy benefit manager industry group, calling the ad "irresponsible."

March 2, 2012

A generic drug maker has launched its version of an Abbott Labs drug.

March 2, 2012

Watson has launched an authorized generic drug for treating postmenopausal women, the company said Friday.

March 1, 2012

Endo's parent company is looking to change its name and will integrate four of its operating units, the drug maker said Thursday.

February 29, 2012

The Food and Drug Administration has approved a drug for epilepsy made by Hi-Tech Pharmacal, the drug maker said Wednesday.

February 29, 2012

A federal district court has turned down a request by Cardinal Health for an injunction against the Drug Enforcement Administration's suspension of the company's license to ship painkiller drugs from one of its distribution centers, the company said Wednesday.

February 29, 2012

Mylan has launched a generic drug for treating depression and anxiety, the company said Wednesday.

February 28, 2012

The Food and Drug Administration on Tuesday announced it will hold a public hearing on March 22 and 23 to discuss how technology can expand which drug products can be switched from prescription to over-the-counter status.